The Crossroads of the Coagulation System and the Immune System: Interactions and Connections

Abstract

The coagulation and immune systems, two vital systems in the human body, share intimate connections that fundamentally determine patient health. These systems work together through several common regulatory pathways, including the Tissue Factor (TF) Pathway. Immune cells expressing TF and producing pro-inflammatory cytokines can influence coagulation, while coagulation factors and processes reciprocally impact immune responses by activating immune cells and controlling their functions. These shared pathways contribute to maintaining health and are also involved in various pathological conditions. Dysregulated coagulation, triggered by infection, inflammation, or tissue damage, can result in conditions such as disseminated intravascular coagulation (DIC). Concurrently, immune dysregulation may lead to coagulation disorders and thrombotic complications. This review elucidates these intricate interactions, emphasizing their roles in the pathogenesis of autoimmune diseases and cancer. Understanding the complex interplay between these systems is critical for disease management and the development of effective treatments. By exploring these common regulatory mechanisms, we can uncover innovative therapeutic strategies targeting these intricate disorders. Thus, this paper presents a comprehensive overview of the mutual interaction between the coagulation and immune systems, highlighting its significance in health maintenance and disease pathology.

Comparative Transcriptomics Analysis Reveals Unique Immune Response to Grass Carp Reovirus Infection in Barbel Chub (Squaliobarbus curriculus)

“…Coagulation factors within the cascade can activate immune cells and promote proinflammatory cytokines, thus directly affecting immune cell function. Moreover, fibrin can act as a scaffold for immune cells, enhancing immune responses [48]. Li et al [49] found that overexpression of the coagulation factor SERPINA1 inhibits GCRV infection.…”

Unraveling the Paradox: Can Anticoagulation Improve Outcomes in Patients With Heart Failure and Increased Bleeding Risk?

“…Moreover, HF leads to the activation of the coagulation cascade through multiple mechanisms. The release of proinflammatory cytokines and neurohormones, such as angiotensin II and catecholamines, stimulates the production of tissue factors and other procoagulant molecules [7]. Additionally, stasis of blood flow in dilated cardiac chambers and reduced cardiac output contribute to blood stagnation, further predisposing to thrombus formation.…”

Revolution in sepsis: a symptoms-based to a systems-based approach?

“…CNS dysfunction, inflammation, endotheliopathy and coagulopathy are all functionally linked through common pathways involved in the regulation of tissue factor (TF) [ 23 , 47 , 48 , 100 , 178 , 179 ]. The common pathways include the TF inhibition pathway, platelet inhibition pathway, the heparin-antithrombin III system, thrombomodulin/protein C system and fibrinolytic pathways (Fig.…”

“…Reconstituted systems are as realistic as our insight into the clotting mechanism allows: extrapolation to physiology should therefore be regarded with due suspicion. Hemker and colleagues [76], p171 CNS dysfunction, inflammation, endotheliopathy and coagulopathy are all functionally linked through common pathways involved in the regulation of tissue factor (TF) [23,47,48,100,178,179]. The common pathways include the TF inhibition pathway, platelet inhibition pathway, the heparin-antithrombin III system, thrombomodulin/ protein C system and fibrinolytic pathways (Fig.…”